{"name":"Kallyope Inc.","slug":"kallyope-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxQbjhoQ0xTNDMzaUdLNGRTSXNPOTVJNlhUeS1OOEZrVVRmRUttOFRfOFhjZmtCMlJkVTNDUkJFTFE4aDM3aHdOUTFOU2JxUHVFSExPSWhLRGZfeEY5M1hEcUxDbEJNRHJiRVBzUzFuUmtGVTc4MmFDb01BNVFTaDB3NGFoREI3emh6MG1oclpQZWpsd3ljZHhFM3RBWU41TXo0Y18xSi1vSVhJV3BLMVdsWENSd25zemJmUEpGNXdXTjZaSUc1TkZhQ1RVdDFNalZGbFB6R1M1LUJWdllRUGM0NEFyN2FHUjdY?oc=5","date":"2026-03-23","type":"trial","source":"Barchart.com","summary":"Diabetes Clinical Trial Pipeline Shows Potential with Active Contributions from 200+ Key Companies | DelveInsight - Barchart.com","headline":"Diabetes Clinical Trial Pipeline Shows Potential with Active Contributions from 200+ Key Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9oNjRVWU1zSWVOLU9uRU1mSE1EejFMdXFLMkZfd3FrS0ZyYlpOMlQ3VWI1NnR6b0hmWEhwU3FVOVp2RlRRZ1hYYUZ0aFpxMkRzZktF?oc=5","date":"2025-11-26","type":"trial","source":"FirstWord Pharma","summary":"Kallyope's neurology reboot hits snag after migraine study stoppage - FirstWord Pharma","headline":"Kallyope's neurology reboot hits snag after migraine study stoppage","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNRzdOSk9QYjdPQlBFbFItbmpMU09FcktoeGlvdW5oay1taG1PNnhpRnpwamxlRV9hU0NsRXEtR1dNZ05mY0VTRHUwR0U3cVc5RGZUQ2VPNmlNN2JzaUVWMVNjeU51Y2htTE9KaHJrSUdmM19acjZvcE5pTXVDazRNRHhOWW03SHYyZTMtMW5jSlVYa3drVUhWMnZteGRWWVRYYUFIeTN4NXczYWV4TkIyTGpWN3V6NGFhdkp1c3p4YTZGZjJCOEV6eUc3OU16UTJtaHRzOWd6VzZBSmE4bExfSmd0R3g0QWlZTFRrS3kzN1Z3aGwtbi1xT0dKWUNGNXdKTE80?oc=5","date":"2025-09-05","type":"pipeline","source":"PR Newswire UK","summary":"GLP-1 Agonists Market to Show Impressive Growth at a CAGR of 10.8% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire UK","headline":"GLP-1 Agonists Market to Show Impressive Growth at a CAGR of 10.8% During the Forecast Period (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9Xd3R5MTluMzY0WlplZXJKUjFYcTA0U3d4MFZ1WTBycktud3Zua2I3LVJIbzdQeFdVcy1Wem5IS1dQNWpYWFdIc0ZjcHdpN0dCazZv?oc=5","date":"2025-02-27","type":"trial","source":"FirstWord Pharma","summary":"Kallyope seems to shift gears to focus on neuro after disappointing weight loss data - FirstWord Pharma","headline":"Kallyope seems to shift gears to focus on neuro after disappointing weight loss data","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE9peTk2bnBZVDRVWVRndnU5dzhmX2s5bzlrZkNPU3M1TlRtZUJGY3BDd3JtSC1wWmZremM0M0o4X2piVVVFOUpOSUpQV3pzSUdfemh5VHdwXzdVM2FDSUJyUkJ1Qk03X1F3SGg4aFI5RmVRQkk?oc=5","date":"2023-10-03","type":"pipeline","source":"labiotech.eu","summary":"Five impactful biotech companies to know in New York - labiotech.eu","headline":"Five impactful biotech companies to know in New York","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNMkZlWFNPSXRKM3hDSW12UzVZYTZBNjdQZFNXeWZQdjVJQUVjSEY5bThkcnV0QUJOcng0Q2hyMkFxZkc4cl9rZGNpZDYwTks3cXpEZTM4NlB6V2g2NmRFZW02cEduS0ZiNmRDU2JUWE00T056Z3V1d3VqR1dkOFkwdkI0NFltVHhmakZSWXlIc1dpU3g4V1k1SW9xaHV4OTZVSU9NOWZzSktiOVZIYjBLM19fUVBjdzNDa3lGNkRjSU5QY2RRbFE?oc=5","date":"2023-06-06","type":"pipeline","source":"Business Wire","summary":"Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors - Business Wire","headline":"Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNVWdkbTRJSlQyWEsySEhjS0tLbnVaQi1zSDVVaEt2ZFppUTQxNTBEOWk3SW1ldGdxMmN1d2h6elF6LWJhU0ZPc1dITFhIR0F4RWlTdVU1NzZrUm1KVXVXX3hYclNmSDhsall0N0s0aEFPQVVVUUdQbHhfRWY1dnowN3I5dTJ3MHc?oc=5","date":"2018-06-20","type":"deal","source":"Yahoo Finance","summary":"Novo Nordisk in Deal with Kallyope for Obesity, Diabetes Drugs - Yahoo Finance","headline":"Novo Nordisk in Deal with Kallyope for Obesity, Diabetes Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNLTFOT2s4WXFUcjF3Uk1mbWFkQ09ZWG1oUl92a0QwM1F5aFZnUmZhOHhLSUg5czZqZDFURUZVaWR6M1E2Qkh1aVBCTUxFcFpSUUR4YXVYaVc3X05ld3NzMjd5TXVMODRyckxlS0YxUWY5Z0EtR24zZmZGeGVCdG9TUVJ5MmVRaE1HTi1pZHA4dC1hWlFCZE5ZSVhEOGtmR2JvSV9VQXhWam5NLV84ckxWckRmYUtrb243YUNHNlJRVXNLV1N0eFplUWgwRG1QMkw2ejFaNDJB?oc=5","date":"2018-02-26","type":"trial","source":"Crain's New York","summary":"Biotech startup Kallyope raises $66M to study the gut-brain connection - Crain's New York","headline":"Biotech startup Kallyope raises $66M to study the gut-brain connection - Crain's New York","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNS1l4X1RPbTc3T3dDM2FIdlQ0d3p6U0ktTFlFUk1MaDFKanExRlRnS2E0RFc1cTBKQXZoZWEzUzh6dzZxaEFmbXNHbndRaUltaVpRTWZKdExBYzdaeUd2c1lvaU41VWtCcHhFbUNCb0UzM2xlakxIWEtMbHV0b3B1aWdmNA?oc=5","date":"2017-10-09","type":"pipeline","source":"Business Insider","summary":"30 Under 40: Young Leaders in Biotech and Pharmaceutical Companies - Business Insider","headline":"30 Under 40: Young Leaders in Biotech and Pharmaceutical Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPWXBCY0lTemRzYjJ4b0lfR1ZLTDJMdVkzM2dhTVl6OGR2a05WUlBrMTktQ2JSclNSZDZYd1Yxd3I1c21Udnh5NkZSTU5Tb0JBcmRGTjlnVVN6elB5c0xDbjh6d0pxcm5MSTRmdnVXSVlEV2hqQnpjUW1Kams3cW1JR1JWSWFiSWpGc1ZqR2Jya2NhNlhJUGdzdjQ1OTlkZXlkTzB3YnpLLWczeG5FeUljd3FtZU1GTmVkMnpsdF82NVlHQ3dSdmVISXVtMA?oc=5","date":"2017-02-27","type":"pipeline","source":"SynBioBeta","summary":"Alexandria LaunchLabs, NYC's Premier Life Science Startup Platform, Selects Its First Member Companies - SynBioBeta","headline":"Alexandria LaunchLabs, NYC's Premier Life Science Startup Platform, Selects Its First Member Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQc1lTM0RyY3VoRHM5cVE0VlV4dU5kN0ZKX29FZmxKMC1sN25SUUlac3E3bzdkSWZhSWk1TV9TQWdaRFltNmZhX0lHeHFHenRQQkt1WVdoSzcxNmNCenBtdWZZRW1YM1ljUzlIaWRDeERfOW9CbUVIZ0oyTkFmWG1qN1VsbUpZcmM5dmZoV2NYenN2bnlKSDFJOVNxR0g4T1FKcDNBVmdhN0NoRkh5cW53TE9n?oc=5","date":"2015-12-11","type":"pipeline","source":"BioPharma Dive","summary":"Kallyope raises $44M in Series A to launch NYC-based ‘gut-brain’ biotech - BioPharma Dive","headline":"Kallyope raises $44M in Series A to launch NYC-based ‘gut-brain’ biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNMnM2Tm04M1B2amIxWlZYSWFvZk9JdkNWVGlUMnpTVjBMYTBfTDBRNEI0SnoxLTd4cE0tNU9ETV9CZERxd2xiZHRuQ1hWTm5sTV9OckNwWnc5SExtNlFsNWxmX2JQZmlTOHZaUjc0clpXaFY0dU5GV3hMMmtXU0cwMDVLUGJRSTFpeEVYeDFBSk5OTmoxdGhjZmwzdkgxajJqRUZxUE14N1JqTUlQUGJiR0NDM1p1QU1RdlpBc0RLQ1QyNEtTcHFFUVowRG53LWhPLUtYaHZsT3IwRERXT1ZBRzd4X1NJbms?oc=5","date":"2015-12-10","type":"pipeline","source":"PR Newswire","summary":"Kallyope Inc. Launches With $44M Series A Financing To Harness The Potential Of The Gut-Brain Axis - PR Newswire","headline":"Kallyope Inc. Launches With $44M Series A Financing To Harness The Potential Of The Gut-Brain Axis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}